Shi M - Search Results

1

A multi-omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma.

Jin X, Liu L, Wu J, Jin X, Yu G, Jia L, Wang F, Shi M, Lu H, Liu J, Liu D, Yang J, Li H, Ni Y, Luo Q, Jia W, Wang W, Chen WL. Jin X, et al. Among authors: shi m. Clin Transl Med. 2021 Sep;11(9):e538. doi: 10.1002/ctm2.538. Clin Transl Med. 2021. PMID: 34586744 Free PMC article.

2

[Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].

Liu CZ, Zhu PY, Shi MX, Liu JB, Liao P, Xiang CQ, Zhang YX, Wang WJ. Liu CZ, et al. Ai Zheng. 2008 Mar;27(3):272-8. Ai Zheng. 2008. PMID: 18334116 Free article. Chinese.

3

Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma.

Liu JB, Qiang FL, Dong J, Cai J, Zhou SH, Shi MX, Chen KP, Hu ZB. Liu JB, et al. World J Gastroenterol. 2011 Nov 28;17(44):4917-21. doi: 10.3748/wjg.v17.i44.4917. World J Gastroenterol. 2011. PMID: 22171134 Free PMC article.

4

ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis.

Wang W, Liu L, Wang Z, Lu X, Wei M, Lin T, Zhang Y, Jiang S, Wang Q, Cao Z, Shi M. Wang W, et al. Among authors: shi m. Cancer Causes Control. 2014 Oct;25(10):1369-77. doi: 10.1007/s10552-014-0442-y. Epub 2014 Jul 27. Cancer Causes Control. 2014. PMID: 25064033

5

Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer.

Wang W, Liu L, Wang Z, Wei M, He Q, Ling T, Cao Z, Zhang Y, Wang Q, Shi M. Wang W, et al. Among authors: shi m. BMC Surg. 2015 Sep 29;15:106. doi: 10.1186/s12893-015-0094-1. BMC Surg. 2015. PMID: 26420728 Free PMC article.

6

Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study.

Liu J, Shen B, Shi M, Cai J. Liu J, et al. Among authors: shi m. PLoS One. 2016 Jan 27;11(1):e0147056. doi: 10.1371/journal.pone.0147056. eCollection 2016. PLoS One. 2016. PMID: 26816289 Free PMC article.

7

A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.

Wang W, Wang Z, Zhao J, Wei M, Zhu X, He Q, Ling T, Chen X, Cao Z, Zhang Y, Liu L, Shi M. Wang W, et al. Among authors: shi m. Oncotarget. 2016 Sep 27;7(39):63526-63536. doi: 10.18632/oncotarget.11362. Oncotarget. 2016. PMID: 27556859 Free PMC article.

8

Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.

Yu F, Liu JB, Wu ZJ, Xie WT, Zhong XJ, Hou LK, Wu W, Lu HM, Jiang XH, Jiang JJ, Cao ZY, Cong GJ, Shi MX, Jia CY, Lu GX, Song YC, Chai L, Lv ZW, Wu CY, Ma YS, Fu D. Yu F, et al. Cancer Lett. 2018 Jul 28;427:74-84. doi: 10.1016/j.canlet.2018.04.022. Epub 2018 Apr 24. Cancer Lett. 2018. PMID: 29702194

9

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer.

Liu L, Shi M, Wang Z, Lu H, Li C, Tao Y, Chen X, Zhao J. Liu L, et al. Among authors: shi m. BMC Cancer. 2018 Oct 11;18(1):966. doi: 10.1186/s12885-018-4881-9. BMC Cancer. 2018. PMID: 30305064 Free PMC article.

10

Prognostic implications of decreased microRNA-101-3p expression in patients with non-small cell lung cancer.

Lu HM, Yi WW, Ma YS, Wu W, Yu F, Fan HW, Lv ZW, Yang HQ, Chang ZY, Zhang C, Xie WT, Jiang JJ, Song YC, Chai L, Jia CY, Lu GX, Zhong XJ, Hou LK, Wu CY, Shi MX, Liu JB, Fu D. Lu HM, et al. Oncol Lett. 2018 Dec;16(6):7048-7056. doi: 10.3892/ol.2018.9559. Epub 2018 Oct 9. Oncol Lett. 2018. PMID: 30546438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,956 results

Search Page

Filters